The Europe medical radiation detection and monitoring market is projected to expand at a CAGR of 7.10% over the forecast period of 2019-2027. The market worth is expected to reach $XX million by the end of this forecast period. The rising incidences of cancer are anticipated to raise the demand for radiation and nuclear medicine therapies.
The United Kingdom market is leading the Europe medical radiation detection and monitoring market. The market growth is mainly propelled by increased usage of radioactive isotopes in the medical industry for diagnosis and treatment of chronic diseases like cancer. Also, several initiatives by the U.K government such as heavy investments to produce these radioactive isotopes and signing of agreements with many international radiation therapy devices manufacturers have considerably contributed to the market growth.
Similarly, the growing cancer cases in Germany is expected to encourage the impacted population to opt for radiation diagnostic solutions, which demands the deployment of radiation detection and monitoring devices. This is a key factor behind the largest shareholding capacity of Germany in the European market over the forecast period.
Fluke Biomedical LLC, AADCO Medical, Inc., Burlington Medical Supplies Inc., Protecx Medical, Unfors RaySafe, Thermo Fisher Scientific Inc., Amray Medical, Bar-Ray, Mirion Technologies, Sun Nuclear Corporation, Infab Corporation, Radiation Detection Company Inc., LANDAUER Inc., Protech Medical, and Kromek Group PLC are few of the well-known companies in this market.